BMRN
BIOMARIN PHARMACEUTICAL INC
Latest close $60.72 as of Aug 4, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 7 parsed filing(s) · 4 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Dec 31, 2025 observed Jan 21, 2026 filed · 21d Schedule 13G amendment | Earliest Schedule 13G amendment found | 17.6M | 12.00% | $59.43 | $56.77 | $60.72 |
| Capital Research Global Investors CIK0001422848 | Mar 31, 2025 observed May 13, 2025 filed · 43d Schedule 13G amendment | Reported accumulation | 190.8M +194.0K | 12.00% 0.00 pts | $59.78 | $60.72 | |
| Capital Research Global Investors CIK0001422848 | Dec 31, 2024 observed Feb 13, 2025 filed · 44d Schedule 13G amendment | Reported accumulation | 190.6M +179.8M | 12.00% +6.30 pts | $60.72 |